ISG12(A), induced by IFN-α and IFN-γ (69), has been identified as an antiviral ISG capable of significantly restricting infections such as hepatitis C virus (HCV) (70), and Newcastle disease virus (NDV) (71). The gene discussed is IFNA1; the disease is infection.